80 related articles for article (PubMed ID: 21411779)
1. Clinical laboratory detection of AmpC β-lactamase: does it affect patient outcome?
Rand KH; Turner B; Seifert H; Hansen C; Johnson JA; Zimmer A
Am J Clin Pathol; 2011 Apr; 135(4):572-6. PubMed ID: 21411779
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.
Pai H; Kang CI; Byeon JH; Lee KD; Park WB; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Oct; 48(10):3720-8. PubMed ID: 15388426
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Huang SS; Lee MH; Leu HS
J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae.
Park YS; Yoo S; Seo MR; Kim JY; Cho YK; Pai H
Int J Antimicrob Agents; 2009 Jul; 34(1):38-43. PubMed ID: 19297134
[TBL] [Abstract][Full Text] [Related]
6. AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases.
Black JA; Moland ES; Thomson KS
J Clin Microbiol; 2005 Jul; 43(7):3110-3. PubMed ID: 16000421
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
[TBL] [Abstract][Full Text] [Related]
8. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004.
Song W; Kim JS; Kim HS; Yong D; Jeong SH; Park MJ; Lee KM
Diagn Microbiol Infect Dis; 2006 Jul; 55(3):219-24. PubMed ID: 16545935
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
11. Phenotype characterization of Beta-lactamase producing enterobacteriaceae in the intensive care unit (ICU) of Cipto Mangunkusumo Hospital in 2011.
Saharman YR; Lestari DC
Acta Med Indones; 2013 Jan; 45(1):11-6. PubMed ID: 23585403
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH
APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
[TBL] [Abstract][Full Text] [Related]
14. Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory.
Pitout JD; Le PG; Moore KL; Church DL; Gregson DB
Clin Microbiol Infect; 2010 Feb; 16(2):165-70. PubMed ID: 19456838
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
16. Extended-spectrum beta-lactamase-producing Enterobacteriaceae at Middlemore Hospital.
Briggs S; Ussher J; Taylor S
N Z Med J; 2005 Jul; 118(1218):U1563. PubMed ID: 16027752
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
Bennett JW; Mende K; Herrera ML; Yu X; Lewis JS; Wickes BL; Jorgensen JH; Murray CK
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):445-8. PubMed ID: 20226336
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes.
Chong YP; Choi SH; Kim ES; Song EH; Lee EJ; Park KH; Cho OH; Kim SH; Lee SO; Kim MN; Jeong JY; Woo JH; Kim YS
Diagn Microbiol Infect Dis; 2010 May; 67(1):70-7. PubMed ID: 20227228
[TBL] [Abstract][Full Text] [Related]
19. Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study.
Noguchi T; Matsumura Y; Yamamoto M; Nagao M; Takakura S; Ichiyama S
BMC Infect Dis; 2017 Jan; 17(1):44. PubMed ID: 28061869
[TBL] [Abstract][Full Text] [Related]
20. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
